We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.2B
AUM Growth
+$1.14B
Cap. Flow
+$754M
Cap. Flow %
4.96%
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$124M
2
TXN icon
Texas Instruments
TXN
+$113M
3
UNH icon
UnitedHealth
UNH
+$106M
4
PM icon
Philip Morris
PM
+$106M
5
TJX icon
TJX Companies
TJX
+$93.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Consumer Discretionary 12.3%
3 Technology 11.57%
4 Communication Services 10.98%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
101
GSK
GSK
$103B
$40.5M 0.27%
841,191
+213,704
+34% +$10.6M
FRC
102
DELISTED
First Republic Bank
FRC
$39.9M 0.26%
432,510
+181,445
+72% +$14.8M
STZ icon
103
Constellation Brands
STZ
$22.2B
$39.8M 0.26%
259,916
-774,928
-75% -$123M
CVS icon
104
CVS Health
CVS
$137B
$39.8M 0.26%
504,781
+437,676
+652% +$35.4M
BAX icon
105
Baxter International
BAX
$11.6B
$39.2M 0.26%
884,192
-813,899
-48% -$37.6M
MRSH
106
Marsh
MRSH
$86.3B
$38.8M 0.26%
574,487
+526,472
+1,096% +$35.3M
FTI icon
107
TechnipFMC
FTI
$30.6B
$38.5M 0.25%
1,457,083
+104,367
+8% +$2.61M
NOC icon
108
Northrop Grumman
NOC
$77B
$38.5M 0.25%
165,514
+149,591
+939% +$34.8M
YUM icon
109
Yum! Brands
YUM
$41B
$37.7M 0.25%
595,965
+268,418
+82% +$16.9M
EA icon
110
Electronic Arts
EA
$52.4B
$37.5M 0.25%
476,115
+449,979
+1,722% +$36.2M
RDC
111
DELISTED
Rowan Companies Plc
RDC
$36.9M 0.24%
1,952,688
+1,037,096
+113% +$16.9M
VAL
112
DELISTED
Valspar
VAL
$36.5M 0.24%
351,924
+203,743
+137% +$21M
DO
113
DELISTED
Diamond Offshore Drilling
DO
$36.4M 0.24%
2,055,891
+1,358,414
+195% +$23.9M
DLTR icon
114
Dollar Tree
DLTR
$23.1B
$36.3M 0.24%
+470,763
New +$37.9M
NVS icon
115
Novartis
NVS
$295B
$36M 0.24%
551,901
+50,724
+10% +$3.29M
BMRN icon
116
BioMarin Pharmaceuticals
BMRN
$11.5B
$35.9M 0.24%
433,641
+294,916
+213% +$25.4M
TNL icon
117
Travel + Leisure Co
TNL
$4.54B
$35.8M 0.24%
1,037,834
+666,483
+179% +$21.4M
CRL icon
118
Charles River Laboratories
CRL
$10.9B
$35.7M 0.24%
469,045
+428,573
+1,059% +$32.5M
ALKS icon
119
Alkermes
ALKS
$8.82B
$35.6M 0.23%
639,670
+320,697
+101% +$17.1M
COST icon
120
Costco
COST
$415B
$35.3M 0.23%
220,295
+48,151
+28% +$7.35M
AXTA icon
121
Axalta
AXTA
$7.01B
$34.9M 0.23%
1,281,838
-1,324,970
-51% -$34.9M
KEX icon
122
Kirby Corp
KEX
$7.95B
$34.8M 0.23%
523,068
+39,409
+8% +$2.49M
TSM icon
123
TSMC
TSM
$2.09T
$34.6M 0.23%
+1,204,228
New +$36.2M
FANG icon
124
Diamondback Energy
FANG
$57.6B
$32.7M 0.22%
324,051
+186,503
+136% +$18.6M
PGR icon
125
Progressive
PGR
$124B
$32.6M 0.21%
918,393
+774,911
+540% +$25.6M

Similar funds

Marshall Wace's Q4 2016 Portfolio in Review

As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $754M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.

  • Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
  • Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
  • Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
  • Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
  • Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
  • Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.

Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.